Modes of escape from therapeutic control in myelomatosis.
D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000009:adverse effects; D002908:Chronic Disease; D006801:Humans; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D009153:Mutagens / Q000494:pharmacology; D011379:Prognosis
D000970:Antineoplastic Agents; D009153:Mutagens